JW Therapeutics Competitors and Similar CompaniesClear all
JW Therapeutics's competitors and similar companies include Eutilex, Zymeworks, Coherus Oncology and Gossamer Bio.
 Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | ||
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2003 | Founding Date 2010 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations CN HQ Suzhou Shi, CN | Locations KR HQ | Locations Vancouver, CA HQ Seattle, US | Locations Redwood City, US HQ Camarillo, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 106 | Employees 141 | Employees 45519% increase | Employees 14736% decrease | Employees 11820% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 85.6 m | Valuation ($) 208 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₩9.5b (FY, 2024) | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₩7b (FY, 2024) | Cost of goods N/A | Cost of goods $13.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ₩2.6b (FY, 2024) | Gross profit N/A | Gross profit $28.4m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income (₩29.5b) (FY, 2024) | Net income ($81.1m) (FY, 2025) | Net income $168m (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 90m | Total funding raised $ 18.9m | Total funding raised $ 125.9m | Total funding raised $ 174.5m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
Eutilex
HQ
KR
Employees
141
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company